Você procurou por: transfusionsrelateret (Dinamarquês - Inglês)

transfusionsrelateret akut lungesygdom
transfusion related acute lung injury

transfusionsrelateret akut lungeskade (trali)
transfusion related acute lung injury (trali)

meget sjældent: transfusionsrelateret akut lungesygdom og tromboemboliske reaktioner såsom hjerteinfarkt, slagtilfælde, lungeemboli og dyb venetrombose.
very rarely: transfusion related acute lung injury and thromboembolic reactions such as myocardial infarction, stroke, pulmonary embolism and deep vein thromboses.

i meget sjældne tilfælde kan transfusionsrelateret akut lungesygdom (trali) forekomme efter behandling med immunglobuliner, herunder privigen.
in very rare cases transfusion-related acute lung injury (trali) can occur after receiving immunoglobulins including privigen.

»tilbagesporing«: efterforskning af indberettet mistanke om transfusionsrelateret bivirkning hos en modtager med henblik på at identificere den donor, der måtte være kilden
‘trace-back’ means the process of investigating a report of a suspected transfusion-associated adverse reaction in a recipient in order to identify a potentially implicated donor;

g) "tilbagesporing": efterforskning af indberettet mistanke om transfusionsrelateret bivirkning hos en modtager med henblik på at identificere den donor, der måtte være kilden
(g) "trace-back" means the process of investigating a report of a suspected transfusion-associated adverse reaction in a recipient in order to identify a potentially implicated donor;

der er rapporteret om non-kardiogent lungeødem (transfusionsrelateret akut lungeskade, trali) hos patienter, der får ivig (herunder kiovig).
there have been reports of noncardiogenic pulmonary edema (transfusion related acute lung injury, trali) in patients administered ivig (including kiovig).

det anbefales at patienter som får cladribine, får bestrålede cellulære blodbestanddele/-produkter for at forebygge transfusionsrelateret graft-versus-host sygdom (ta-gvhd).
it is recommended that patients receiving cladribine should receive irradiated cellular blood components/products to prevent transfusion-related graft-versus-host disease (ta-gvhd).